Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.27B |
| 2 |
SNDK
Sandisk
SNDK
|
+$674M |
| 3 |
Credo Technology Group
CRDO
|
+$476M |
| 4 |
NBIS
Nebius Group N.V.
NBIS
|
+$452M |
| 5 |
Vertiv
VRT
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.98B |
| 2 |
Amazon
AMZN
|
+$1.25B |
| 3 |
Shopify
SHOP
|
+$1.08B |
| 4 |
Edwards Lifesciences
EW
|
+$1.07B |
| 5 |
Microsoft
MSFT
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 43.11% |
| 2 | Communication Services | 13.94% |
| 3 | Consumer Discretionary | 10.64% |
| 4 | Industrials | 9.08% |
| 5 | Healthcare | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vaxcyte
PCVX
$8.9B
| $27.7M | 0.02% |
476,216
-1,221,795
| -72% | -$66.4M |
|
302
Hershey
HSY
$36B
| $27.5M | 0.02% |
156,540
+152,694
| +3,970% | +$28.8M |
|
303
Spyre Therapeutics
SYRE
$7.97B
| $26.9M | 0.02% |
+303,180
| New | +$22.1M |
|
304
Plains GP Holdings
PAGP
$5.54B
| $26.8M | 0.02% |
1,105,491
-21,336
| -2% | -$512K |
|
305
Steel Dynamics
STLD
$33.6B
| $26.8M | 0.02% |
116,865
+6,835
| +6% | +$1.6M |
|
|
AVLN
306
Avalyn Pharma
AVLN
$1.54B
| $26.8M | 0.02% |
+812,749
| New | +$23.5M |
|
|
GRDN
307
Guardian Pharmacy Services
GRDN
$2.35B
| $26.2M | 0.02% |
626,664
-196,120
| -24% | -$7.59M |
|
|
ABVX
308
Abivax
ABVX
$9.89B
| $26.2M | 0.02% |
196,524
-14,010
| -7% | -$1.59M |
|
309
Enterprise Products Partners
EPD
$84.3B
| $25.9M | 0.02% |
704,938
-13,605
| -2% | -$513K |
|
310
Saia
SAIA
$9.37B
| $25.9M | 0.02% |
+61,433
| New | +$27M |
|
311
Dutch Bros
BROS
$6.88B
| $25.9M | 0.02% |
360,198
-12,990
| -3% | -$745K |
|
|
NSA
312
DELISTED
National Storage Affiliates Trust
NSA
| $25.3M | 0.02% |
568,448
-705,964
| -55% | -$30.3M |
|
313
MPLX
MPLX
$60.1B
| $24.9M | 0.01% |
441,796
-103,274
| -19% | -$5.76M |
|
|
FRVO
314
Fervo Energy
FRVO
$4.35B
| $24.6M | 0.01% |
+843,161
| New | +$30.4M |
|
315
Century Communities
CCS
$1.97B
| $24.5M | 0.01% |
341,906
-7,606
| -2% | -$440K |
|
316
CBRE Group
CBRE
$43.7B
| $24M | 0.01% |
178,000
-86,097
| -33% | -$11.9M |
|
317
Antero Midstream
AM
$10.6B
| $23.9M | 0.01% |
1,050,469
-19,653
| -2% | -$427K |
|
318
TransDigm Group
TDG
$65.6B
| $23.6M | 0.01% |
17,717
+20
| +0.1% | +$24.6K |
|
|
SPTX
319
Seaport Therapeutics
SPTX
$1.29B
| $23.5M | 0.01% |
+1,079,669
| New | +$19M |
|
320
Pinnacle West Capital
PNW
$11.8B
| $23.4M | 0.01% |
218,930
-7,123
| -3% | -$728K |
|
321
Cohu
COHU
$2.27B
| $23.3M | 0.01% |
+314,865
| New | +$15.7M |
|
|
INIO
322
INNIO N.V.
INIO
$15.6B
| $23.2M | 0.01% |
+586,973
| New | +$20.9M |
|
323
BWX Technologies
BWXT
$14B
| $23.1M | 0.01% |
118,548
-153
| -0.1% | -$31.9K |
|
324
CG Oncology
CGON
$6.59B
| $22.5M | 0.01% |
317,235
-158,901
| -33% | -$10.4M |
|
325
iShares MSCI ACWI ex US ETF
ACWX
$12.5B
| $22.5M | 0.01% |
296,085
-252,932
| -46% | -$18.8M |
|
Similar funds
Jennison Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Jennison Associates held 641 positions worth $167B, up 15% from $145B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Jennison Associates withdrew a net $6.22B in Q2 2026, closing 74 positions and reducing 282 holdings. Its most notable exit was Gilead Sciences, an estimated $176M position sold in full.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Jennison Associates opened a new position in SpaceX worth $1.27B.
- Jennison Associates's largest Q2 2026 buy was SpaceX: 7,448,891 shares worth $1.27B.
- Jennison Associates added most to Credo Technology Group in Q2 2026, an estimated $476M increase.
- Jennison Associates's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.98B.
- Jennison Associates fully exited Gilead Sciences in Q2 2026, selling an estimated $176M.
- Jennison Associates's ten largest holdings make up 45% of its $167B portfolio in Q2 2026.
- Jennison Associates opened 79 new positions and closed 74 in Q2 2026.
- Jennison Associates's portfolio value rose 15% quarter-over-quarter to $167B.
Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.